Us Infectious Vaccines Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Infectious Vaccines Market was valued at USD 40 Billion in 2022 and is projected to reach USD 72 Billion by 2030, growing at a CAGR of 8.0% from 2024 to 2030.
The US Infectious Vaccines Market has witnessed significant growth in recent years, driven by the increasing prevalence of infectious diseases and advancements in vaccine technology. As the demand for innovative and effective vaccines rises, the market is expected to continue its upward trajectory. The market has been significantly impacted by the COVID-19 pandemic, which accelerated vaccine research and development efforts. According to recent data, the US infectious vaccines market is expected to reach over $30 billion by 2027, with a robust compound annual growth rate (CAGR) of 6.5% from 2021 to 2027.
One of the key drivers of the market is the growing focus on the development of vaccines targeting diseases such as influenza, hepatitis, pneumococcal diseases, and emerging infectious diseases. The ongoing research in biotechnology and genetic engineering has led to the creation of mRNA vaccines, which have shown significant promise in preventing various infectious diseases. The rise of personalized medicine is another trend influencing vaccine development, as healthcare providers increasingly tailor vaccines based on individual genetic profiles to enhance their effectiveness.
The increasing awareness about preventive healthcare and the government's proactive role in funding vaccine research further boost the market. The US Centers for Disease Control and Prevention (CDC) and other public health organizations continue to advocate for vaccination as a means to curb the spread of infectious diseases. With the integration of advanced technologies, such as 100 Gigabit Fiber Optic Transceiver in data transmission, the ability to share vaccine-related information and track immunization rates has improved significantly.
Key players in the market include major pharmaceutical companies such as Pfizer, Moderna, and Johnson & Johnson, who have pioneered COVID-19 vaccines and are now expanding their infectious vaccine portfolios. With an ever-evolving landscape, the US infectious vaccines market remains a crucial segment in global healthcare, offering hope for better disease control and improved public health outcomes.
Get an In-Depth Research Analysis of the Global Infectious Vaccines Market Size And Forecast [2025-2032]
Â
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc (U.S.)
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Infectious Vaccines Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Infectious Vaccines Market
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Subunit Vaccines
mRNA Vaccines
DNA Vaccines
Viral Infections
Bacterial Infections
Parasitic Infections
Injectable Vaccines
Oral Vaccines
Intranasal Vaccines
Healthcare Providers
Pharmaceutical Companies
Government and NGOs
Research Institutions
Pediatric Vaccines
Adult Vaccines
Geriatric Vaccines
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Infectious Vaccines Market Research Analysis
1. Introduction of the Global Infectious Vaccines Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Infectious Vaccines Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Infectious Vaccines Market, By Type
6. Global Infectious Vaccines Market, By Application
7. Global Infectious Vaccines Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Infectious Vaccines Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/